Ngā hua rapu kaituhi :: APM

1

One year outcome of undifferentiated polyarthritis mā Jansen, L, van Schaardenburg, D, van der Horst-Bru..., I E, Dijkmans, B

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Predictors of functional status in patients with early rheumatoid arthritis mā Jansen, L, van Schaardenburg, D, van der Horst-Bru..., I E, Bezemer, P, Dijkmans, B

I whakaputaina 2000

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Predictors of radiographic joint damage in patients with early rheumatoid arthritis mā Jansen, L, van der Horst-Bru..., I E, van Schaardenburg, D, Bezemer, P, Dijkmans, B

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Influence of HLA polymorphism on persistent remission in rheumatoid arthritis mā Molenaar, E, Voskuyl, A, van der Horst-Bru..., I E, Schreuder, G, Zanelli, E, Dijkmans, B

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor ß1 (TGFB1) gene polymorphisms mā van der Paardt, M, Crusius, J, Garcia-Gonzalez, M, Dijkmans, B, Pena, A, van der Horst-Bru..., I E

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis mā van Denderen, J C, van der Paardt, M, Nurmohamed, M, de Ryck, Y M M A, Dijkmans, B, van der Horst-Bru..., I E

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Prevalence of Chlamydia trachomatis in urine of male patients with ankylosing spondylitis is not increased mā van der Paardt, M, van Denderen, J C, van den Brule, A J C, Morre, S, van der Horst-Bru..., I E, Bezemer, P, Dijkmans, B

I whakaputaina 2000

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother mā van der Horst-Bru..., I E, de Vries, R R P, de Buck, P D M, van Schendel, P W, Breedveld, F, Schreuder, G, Hazes, J

I whakaputaina 1998

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis mā van der Paardt, M, Crusius, J, de Koning, M H M T, Morre, S, van de Stadt, R J, Dijkmans, B, Pena, A, van der Horst-Bru..., I E

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis mā Nielen, M, van der Horst, A R, van Schaardenburg, D, van der Horst-Bru..., I E, van de Stadt, R J, Aarden, L, Dijkmans, B, Hamann, D

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Influence of non-inherited maternal HLA-DR antigens on susceptibility to rheumatoid arthritis mā van der Horst-Bru..., I E, Hazes, J, Schreuder, G, Radstake, T, Barrera, P, van de Putte, L B A, Mustamu, D, van Schaardenburg, D, Breedveld, F, de Vries, R R P

I whakaputaina 1998

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i: